TFC timeline
Every TFC batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| TFC-2608-J5420 | Retatrutide | 25 Aug 2026 | 2026-Q3 | 2 | 98.06 | 0.73 | 98.60 | +0.54 | |
| TFC-2608-S5204 | Humanin (HNG) | 12 Aug 2026 | 2026-Q3 | 2 | 98.43 | 0.06 | 99.11 | +0.68 | |
| TFC-2607-R4363 | SS-31 (Elamipretide) | 20 Jul 2026 | 2026-Q3 | 1 | 99.56 | n<2 | 99.90 | +0.34 | |
| TFC-2605-H7009 | Enclomiphene citrate | 29 May 2026 | 2026-Q2 | 5 | 99.32 | 1.09 | 99.86 | +0.54 | |
| TFC-2605-R4770 | MOTS-c | 26 May 2026 | 2026-Q2 | 2 | 99.69 | 0.07 | 99.84 | +0.15 | |
| TFC-2605-U5564 | Humanin (HNG) | 23 May 2026 | 2026-Q3 | 10 | 99.80 | 0.74 | 99.75 | -0.05 | |
| TFC-2605-G5134 | Tirzepatide | 23 May 2026 | 2026-Q3 | 5 | 98.44 | 0.52 | 99.11 | +0.67 | SHARED BULK |
| TFC-2605-Y6440 | Sermorelin | 16 May 2026 | 2026-Q3 | 7 | 98.71 | 1.37 | 99.08 | +0.37 | |
| TFC-2605-P7517 | CJC-1295 with DAC | 02 May 2026 | 2026-Q2 | 2 | 98.85 | 0.39 | 98.84 | -0.01 | |
| TFC-2604-A4630 | BPC-157 | 26 Apr 2026 | 2026-Q2 | 1 | 99.47 | n<2 | 99.90 | +0.43 | |
| TFC-2604-X4301 | Semaglutide | 17 Apr 2026 | 2026-Q3 | 9 | 98.91 | 1.35 | 98.86 | -0.05 | |
| TFC-2604-Y7472 | SS-31 (Elamipretide) | 14 Apr 2026 | 2026-Q3 | 6 | 98.13 | 1.00 | 99.08 | +0.95 | SHARED BULK |
| TFC-2604-B6683 | Kisspeptin-10 | 03 Apr 2026 | 2026-Q2 | 3 | 98.82 | 0.65 | 99.66 | +0.84 | |
| TFC-2603-M6766 | Ipamorelin | 19 Mar 2026 | 2026-Q2 | 7 | 99.93 | 0.23 | 99.90 | -0.03 | |
| TFC-2602-F4591 | Semax | 16 Feb 2026 | 2026-Q2 | 12 | 99.34 | 1.19 | 99.88 | +0.54 | |
| TFC-2602-H5189 | Semaglutide | 09 Feb 2026 | 2026-Q1 | 3 | 98.85 | 0.67 | 99.35 | +0.50 | |
| TFC-2601-L7836 | MK-677 (Ibutamoren mesylate) | 14 Jan 2026 | 2026-Q1 | 3 | 99.93 | 0.35 | 99.90 | -0.03 | |
| TFC-2601-L7201 | Afamelanotide | 02 Jan 2026 | 2026-Q2 | 2 | 99.72 | 0.40 | 99.90 | +0.18 | |
| TFC-2512-V7681 | PT-141 (Bremelanotide) | 25 Dec 2025 | 2026-Q2 | 13 | 99.17 | 1.53 | 99.90 | +0.73 | |
| TFC-2512-G7985 | Retatrutide | 15 Dec 2025 | 2026-Q2 | 13 | 98.73 | 1.23 | 99.17 | +0.44 | |
| TFC-2512-L7022 | BPC-157 | 11 Dec 2025 | 2026-Q1 | 7 | 98.86 | 0.32 | 99.45 | +0.59 | |
| TFC-2512-M8211 | PT-141 (Bremelanotide) | 08 Dec 2025 | 2026-Q2 | 9 | 99.13 | 0.74 | 99.51 | +0.38 | |
| TFC-2511-N5622 | MK-677 (Ibutamoren mesylate) | 27 Nov 2025 | 2025-Q4 | 1 | 99.34 | n<2 | 99.79 | +0.45 | |
| TFC-2511-E6528 | Liraglutide | 13 Nov 2025 | 2026-Q2 | 5 | 98.68 | 1.57 | 99.24 | +0.56 | |
| TFC-2511-C8532 | BPC-157 | 11 Nov 2025 | 2025-Q4 | 3 | 98.60 | 0.22 | 99.00 | +0.40 | SHARED BULK |
| TFC-2511-S4569 | BPC-157 | 06 Nov 2025 | 2026-Q2 | 1 | 99.92 | n<2 | 99.90 | -0.02 | |
| TFC-2511-L5476 | AOD-9604 | 06 Nov 2025 | 2025-Q4 | 14 | 99.69 | 0.75 | 99.90 | +0.21 | |
| TFC-2511-C6410 | Selank | 06 Nov 2025 | 2025-Q4 | 6 | 99.92 | 0.57 | 99.90 | -0.02 | |
| TFC-2511-E6450 | Gonadorelin | 03 Nov 2025 | 2026-Q2 | 8 | 99.51 | 0.84 | 99.88 | +0.37 | |
| TFC-2511-E5198 | Epitalon | 02 Nov 2025 | 2026-Q1 | 1 | 98.44 | n<2 | 99.77 | +1.33 | SHARED BULK |
| TFC-2510-V8050 | GHRP-6 | 12 Oct 2025 | 2025-Q4 | 1 | 99.22 | n<2 | 99.90 | +0.68 | SHARED BULK |
| TFC-2510-C7425 | Liraglutide | 01 Oct 2025 | 2025-Q4 | 11 | 99.00 | 1.79 | 99.22 | +0.22 | |
| TFC-2508-M4888 | KPV | 29 Aug 2025 | 2026-Q1 | 9 | 99.78 | 0.69 | 99.90 | +0.12 | |
| TFC-2508-L6063 | Retatrutide | 29 Aug 2025 | 2025-Q3 | 3 | 97.71 | 1.05 | 98.50 | +0.79 | |
| TFC-2508-H7325 | Retatrutide | 26 Aug 2025 | 2025-Q3 | 9 | 97.81 | 0.74 | 97.72 | -0.09 | |
| TFC-2508-W5717 | BPC-157 | 25 Aug 2025 | 2025-Q3 | 6 | 99.68 | 0.68 | 99.65 | -0.03 | |
| TFC-2508-L6321 | 5-Amino-1MQ | 22 Aug 2025 | 2026-Q1 | 5 | 99.81 | 0.69 | 99.90 | +0.09 | |
| TFC-2508-H6012 | IGF-1 LR3 | 20 Aug 2025 | 2025-Q3 | 5 | 97.75 | 1.14 | 98.12 | +0.37 | |
| TFC-2508-V4179 | Retatrutide | 19 Aug 2025 | 2026-Q1 | 1 | 98.16 | n<2 | 98.86 | +0.70 | |
| TFC-2508-A5297 | Semaglutide | 17 Aug 2025 | 2026-Q1 | 12 | 98.65 | 1.49 | 99.82 | +1.17 | |
| TFC-2508-W5644 | Epitalon | 15 Aug 2025 | 2026-Q1 | 9 | 98.85 | 0.82 | 99.30 | +0.45 | |
| TFC-2508-L6746 | Tirzepatide | 09 Aug 2025 | 2026-Q1 | 11 | 98.16 | 1.43 | 98.69 | +0.53 | |
| TFC-2508-G5717 | Tirzepatide | 08 Aug 2025 | 2025-Q3 | 1 | 98.90 | n<2 | 99.50 | +0.60 | |
| TFC-2507-K7301 | Semaglutide | 28 Jul 2025 | 2025-Q4 | 5 | 98.56 | 0.73 | 98.50 | -0.06 | |
| TFC-2507-C4489 | CJC-1295 (no DAC) | 17 Jul 2025 | 2025-Q4 | 2 | 99.24 | 1.12 | 99.52 | +0.28 | |
| TFC-2507-M4201 | PEG-MGF | 09 Jul 2025 | 2025-Q3 | 10 | 98.03 | 1.50 | 98.50 | +0.47 | |
| TFC-2507-J6580 | BPC-157 | 08 Jul 2025 | 2025-Q3 | 3 | 99.37 | 1.16 | 99.52 | +0.15 | |
| TFC-2507-T5380 | Tirzepatide | 07 Jul 2025 | 2025-Q3 | 8 | 98.02 | 0.95 | 98.24 | +0.22 | |
| TFC-2507-U5442 | Semaglutide | 01 Jul 2025 | 2025-Q4 | 8 | 99.16 | 1.07 | 99.64 | +0.48 | |
| TFC-2505-A5030 | Selank | 27 May 2025 | 2025-Q4 | 2 | 98.70 | 0.60 | 99.60 | +0.90 | |
| TFC-2505-C6056 | NAD+ | 20 May 2025 | 2025-Q3 | 4 | 99.43 | 0.70 | 100.00 | +0.57 | |
| TFC-2505-H6901 | Semax | 15 May 2025 | 2025-Q4 | 1 | 99.19 | n<2 | 99.90 | +0.71 | |
| TFC-2505-N7258 | MK-677 (Ibutamoren mesylate) | 10 May 2025 | 2025-Q2 | 11 | 99.32 | 0.69 | 99.52 | +0.20 | |
| TFC-2505-V7070 | MOTS-c | 06 May 2025 | 2025-Q3 | 1 | 98.71 | n<2 | 99.53 | +0.82 | |
| TFC-2504-J6965 | BPC-157 | 24 Apr 2025 | 2025-Q2 | 4 | 99.38 | 1.02 | 100.00 | +0.62 | |
| TFC-2504-G6596 | Selank | 17 Apr 2025 | 2025-Q3 | 1 | 99.04 | n<2 | 99.75 | +0.71 | |
| TFC-2503-E5248 | VIP | 27 Mar 2025 | 2025-Q2 | 2 | 99.00 | 0.69 | 99.17 | +0.17 | |
| TFC-2503-A8165 | Gonadorelin | 26 Mar 2025 | 2025-Q3 | 5 | 99.47 | 0.37 | 99.75 | +0.28 | |
| TFC-2503-R5803 | TB-500 | 25 Mar 2025 | 2025-Q3 | 4 | 99.01 | 0.73 | 99.73 | +0.72 | |
| TFC-2503-C7376 | MOTS-c | 23 Mar 2025 | 2025-Q3 | 7 | 99.37 | 1.26 | 99.18 | -0.19 | |
| TFC-2503-X7298 | Retatrutide | 20 Mar 2025 | 2025-Q3 | 6 | 98.91 | 0.72 | 99.46 | +0.55 | |
| TFC-2503-L5055 | TB-500 | 15 Mar 2025 | 2025-Q3 | 1 | 98.99 | n<2 | 99.90 | +0.91 | |
| TFC-2503-P7552 | Tirzepatide | 09 Mar 2025 | 2025-Q3 | 13 | 98.84 | 1.43 | 99.38 | +0.54 | |
| TFC-2502-L6365 | Semaglutide | 27 Feb 2025 | 2025-Q1 | 14 | 98.16 | 2.26 | 98.60 | +0.44 | |
| TFC-2502-Y6610 | Afamelanotide | 26 Feb 2025 | 2025-Q1 | 3 | 98.90 | 0.43 | 99.70 | +0.80 | |
| TFC-2502-E7857 | Epitalon | 10 Feb 2025 | 2025-Q1 | 1 | 99.50 | n<2 | 99.90 | +0.40 | |
| TFC-2502-D6597 | GHRP-2 | 09 Feb 2025 | 2025-Q1 | 2 | 99.32 | 0.77 | 99.77 | +0.45 | |
| TFC-2501-K7199 | ARA-290 | 29 Jan 2025 | 2025-Q2 | 7 | 99.87 | 0.60 | 99.90 | +0.03 | |
| TFC-2412-A6202 | TB-500 | 12 Dec 2024 | 2025-Q1 | 12 | 99.93 | 0.37 | 99.90 | -0.03 | |
| TFC-2411-R5803 | Adipotide | 29 Nov 2024 | 2025-Q2 | 2 | 98.60 | 0.61 | 99.22 | +0.62 | |
| TFC-2411-M5192 | CJC-1295 (no DAC) | 21 Nov 2024 | 2025-Q2 | 6 | 98.84 | 0.67 | 99.61 | +0.77 | |
| TFC-2411-F7283 | N-Acetyl Semax Amide | 20 Nov 2024 | 2025-Q2 | 2 | 98.49 | 0.07 | 99.90 | +1.41 | |
| TFC-2411-A6347 | GHRP-2 | 19 Nov 2024 | 2025-Q1 | 7 | 99.32 | 0.82 | 99.90 | +0.58 | |
| TFC-2410-F6246 | SS-31 (Elamipretide) | 29 Oct 2024 | 2024-Q4 | 3 | 99.03 | 0.50 | 100.00 | +0.97 | |
| TFC-2410-R6501 | Melanotan II | 19 Oct 2024 | 2025-Q1 | 1 | 99.88 | n<2 | 99.90 | +0.02 | |
| TFC-2410-N7616 | LL-37 | 15 Oct 2024 | 2025-Q1 | 10 | 98.17 | 1.12 | 98.85 | +0.68 | |
| TFC-2410-N5362 | ARA-290 | 09 Oct 2024 | 2024-Q4 | 10 | 99.81 | 0.68 | 99.90 | +0.09 | |
| TFC-2409-U6527 | Dihexa | 30 Sep 2024 | 2025-Q1 | 12 | 99.51 | 1.01 | 99.82 | +0.31 | |
| TFC-2409-S7358 | Semaglutide | 26 Sep 2024 | 2024-Q4 | 6 | 99.24 | 0.39 | 99.41 | +0.17 | |
| TFC-2409-H7264 | Retatrutide | 19 Sep 2024 | 2024-Q4 | 10 | 97.62 | 1.38 | 97.56 | -0.06 | |
| TFC-2409-Y6260 | Survodutide | 18 Sep 2024 | 2025-Q1 | 13 | 98.97 | 1.48 | 99.82 | +0.85 | |
| TFC-2409-W5949 | Exenatide | 17 Sep 2024 | 2024-Q4 | 8 | 99.83 | 0.35 | 99.90 | +0.07 | |
| TFC-2408-T4425 | Ipamorelin | 31 Aug 2024 | 2025-Q1 | 9 | 99.08 | 0.66 | 99.41 | +0.33 | |
| TFC-2408-M8176 | MGF | 30 Aug 2024 | 2024-Q4 | 2 | 99.52 | 0.14 | 99.90 | +0.38 | |
| TFC-2406-V7696 | Liraglutide | 30 Jun 2024 | 2024-Q3 | 14 | 99.57 | 0.93 | 100.00 | +0.43 | |
| TFC-2406-P6141 | IGF-1 LR3 | 10 Jun 2024 | 2024-Q4 | 1 | 97.79 | n<2 | 98.16 | +0.37 | |
| TFC-2406-A6033 | 5-Amino-1MQ | 06 Jun 2024 | 2024-Q4 | 4 | 99.04 | 0.56 | 99.36 | +0.32 | |
| TFC-2405-J8155 | TB-500 | 21 May 2024 | 2024-Q3 | 8 | 99.14 | 1.21 | 99.90 | +0.76 | |
| TFC-2405-W5763 | Tirzepatide | 03 May 2024 | 2024-Q2 | 6 | 97.78 | 1.52 | 98.43 | +0.65 | |
| TFC-2404-J4890 | Enclomiphene citrate | 24 Apr 2024 | 2024-Q3 | 3 | 99.58 | 0.75 | 99.81 | +0.23 | |
| TFC-2404-U6212 | Tirzepatide | 11 Apr 2024 | 2024-Q2 | 5 | 99.30 | 1.22 | 99.65 | +0.35 | |
| TFC-2403-Y7884 | Pramlintide | 27 Mar 2024 | 2024-Q3 | 10 | 98.62 | 1.11 | 99.26 | +0.64 | |
| TFC-2402-L6506 | AOD-9604 | 12 Feb 2024 | 2024-Q2 | 1 | 99.74 | n<2 | 99.49 | -0.25 | |
| TFC-2402-N4840 | Kisspeptin-10 | 10 Feb 2024 | 2024-Q3 | 2 | 99.37 | 0.19 | 99.90 | +0.53 | |
| TFC-2401-J7929 | Tirzepatide | 18 Jan 2024 | 2024-Q1 | 12 | 98.00 | 2.09 | 98.62 | +0.62 | |
| TFC-2401-J4881 | Melanotan II | 03 Jan 2024 | 2024-Q2 | 13 | 99.18 | 1.28 | 99.90 | +0.72 | |
| TFC-2312-P7493 | Tirzepatide | 12 Dec 2023 | 2024-Q2 | 4 | 98.07 | 0.57 | 98.88 | +0.81 | |
| TFC-2310-J5460 | PT-141 (Bremelanotide) | 05 Oct 2023 | 2024-Q1 | 4 | 99.53 | 1.31 | 99.90 | +0.37 | |
| TFC-2309-H6661 | Retatrutide | 26 Sep 2023 | 2024-Q1 | 2 | 99.09 | 0.21 | 99.43 | +0.34 |